The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer's disease and Parkinson's disease

G Monzio Compagnoni, A Di Fonzo, S Corti… - Molecular …, 2020 - Springer
Although the pathogenesis of neurodegenerative diseases is still widely unclear, various
mechanisms have been proposed and several pieces of evidence are supportive for an …

Determinants of dopaminergic neuron loss in Parkinson's disease

DJ Surmeier - The FEBS journal, 2018 - Wiley Online Library
The cardinal motor symptoms of Parkinson's disease (PD) are caused by the death of
dopaminergic neurons in the substantia nigra pars compacta (SN c). Alpha‐synuclein …

Understanding dopaminergic cell death pathways in Parkinson disease

PP Michel, EC Hirsch, S Hunot - Neuron, 2016 - cell.com
Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiology of which
remains largely unknown. Progressive impairment of voluntary motor control, which …

Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease

LP Dolgacheva, AV Berezhnov, EI Fedotova… - Journal of Bioenergetics …, 2019 - Springer
DJ-1 protein has multiple specific mechanisms to protect dopaminergic neurons against
neurodegeneration in Parkinson's disease. Wild type DJ-1 can acts as oxidative stress …

Rotenone-induced model of Parkinson's disease: Beyond mitochondrial complex I inhibition

MT Ibarra-Gutiérrez, N Serrano-García… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is usually diagnosed through motor symptoms that make the
patient incapable of carrying out daily activities; however, numerous non-motor symptoms …

Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin

G Ashrafi, JS Schlehe, MJ LaVoie, TL Schwarz - Journal of Cell Biology, 2014 - rupress.org
To minimize oxidative damage to the cell, malfunctioning mitochondria need to be removed
by mitophagy. In neuronal axons, mitochondrial damage may occur in distal regions, far from …

[HTML][HTML] Microglial activation and chronic neurodegeneration

ME Lull, ML Block - Neurotherapeutics, 2010 - Elsevier
Microglia, the resident innate immune cells in the brain, have long been implicated in the
pathology of neurodegenerative diseases. Accumulating evidence points to activated …

PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

B Zheng, Z Liao, JJ Locascio, KA Lesniak… - Science translational …, 2010 - science.org
Parkinson's disease affects 5 million people worldwide, but the molecular mechanisms
underlying its pathogenesis are still unclear. Here, we report a genome-wide meta-analysis …

Mitochondrial membrane permeabilization in cell death

G Kroemer, L Galluzzi, C Brenner - Physiological reviews, 2007 - journals.physiology.org
Irrespective of the morphological features of end-stage cell death (that may be apoptotic,
necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is …

[HTML][HTML] Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

J St-Pierre, S Drori, M Uldry, JM Silvaggi, J Rhee… - Cell, 2006 - cell.com
PPARγ coactivator 1α (PGC-1α) is a potent stimulator of mitochondrial biogenesis and
respiration. Since the mitochondrial electron transport chain is the main producer of reactive …